FindTrial
Sign In

Study on the causes and treatment strategies of diazoxide ineffective congenital hyperinsulinemia

Study on the causes and treatment strategies of diazoxide ineffective congenital hyperinsulinemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016089
Enrollment
Unknown
Registered
2018-05-10
Start date
2014-08-09
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital hyperinsulinism

Interventions

Case series:N/A

Sponsors

Beijing Children's Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Diagnosis of congenital hyperinsulinemia

Exclusion criteria

Exclusion criteria: Diagnosis of incongenitally hyperinsulinemia

Design outcomes

Primary

MeasureTime frame
Two generation gene sequencing (gene mutation is positive or negative);—

Countries

China

Contacts

Public ContactSang YM

Beijing Children's Hospital affiliated to Capital Medical University

289108564@qq.com+86 13910668087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026